May 14, 2026
Solving the Data Challenge in Ophthalmic AI
At ARVO, Cecilia S. Lee, MD, MS, and Aaron Y. Lee, MD, MSCI, discuss barriers to AI deployment in ophthalmology, including interoperability and model development.
The 2026 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
May 03, 2026 - April 07, 2026
Denver, Colorado
The ARVO 2026 Annual Meeting is a premier global gathering for eye and vision research, bringing together investigators, clinicians, and industry professionals from around the world to share the latest advances in vision science. The meeting offers access to new research across basic, translational, and clinical disciplines, along with continuing education, mentorship, and networking opportunities. ARVO and the ARVO Foundation also support attendees through awards and grants designed to advance research and facilitate meeting participation.
Related Content
May 7, 2026
The Data Bottleneck in AI Adoption
In his keynote talk at the Focus A-Eye Summit, Euan Thomson explained why health care AI progress depends on creating a unified data ecosystem.
May 7, 2026
Precision Medicine in Focus at ARVO
ARVO retina program committee member Jay Chhablani, MD, reviews key themes of the meeting, including precision medicine, imaging, and emerging data.
May 6, 2026
OCT Shows Slowing of Structural Glaucoma Progression After SLT
“Results suggest that SLT may help slow progression of glaucomatous damage over time,” said Raeesah Ahsan, BA, in her presentation.
May 6, 2026
RESTORE Phase 2b/3 Trial Data Show Lasting BCVA Improvement in RP Patients
MCO-010 demonstrated sustained, clinically meaningful BCVA improvement over 3 years with favorable safety, supporting durable efficacy.
May 6, 2026
Multichannel Femtosecond Laser Surgery Shows Promise for Glaucoma
Data from a study presented at ARVO indicated better outflow could be achieved with 2 channels than with 1.
May 6, 2026
New Tools for Imaging Retinal Inflammation
At ARVO 2026, Ethan A. Rossi, PhD, presented data on multimodal AOSLO imaging of immune cells in the living eye.
May 5, 2026
AI Assistance in Identifying Retinal Disease Biomarkers in OCT Scans
Results demonstrated that use of AI reports in evaluations improved disease detection by 42% overall.
January 2, 2026
Prevent Blindness Takes Part in National Glaucoma Awareness Month With New Webinar
As part of National Glaucoma Awareness Month in January, Prevent Blindness announced the availability of free educational resources on glaucoma that eyecare professionals can share with their patients.